It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Alkermes plc (ALKS) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.31, or 1.04%, to $30.24. The Alkermes plc has recorded 30,271 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed Alkermes Presents Clinical and Real-World Data at 36th Annual Psych Congress.
Alkermes plc is listed on the NASDAQ in the Healthcare sector while operating in the Drug Manufacturers – Specialty & Generic industry. At the end of the last regular session, the stock closed at $29.93 and fluctuated between $29.99 as its day high and $29.21 as its day low. The current market capitalization of Alkermes plc is $5.03B. A total of 2.15 million shares were traded on the day, compared to an average of 1.75M shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, ALKS has seen 11 BUY and 11 SELL insider trades, representing the acquisition of 61,544 and the disposition of 16,845 shares. Over the last 12 months, there were 56 BUYs and 52 SELLs from insiders. Insiders purchased 589,056 shares during that period but sold 245,964.
In the most recent transaction, LAURENCIN CATO T sold 2,638 shares of ALKS for 31.85 per share on Jun 08. After the transaction, the Director now owns 7,479 company shares. In a previous transaction on Jun 07, LAURENCIN CATO T sold 2,800 shares at 31.50 per share. ALKS shares that Director owns now total 7,479.
Among the insiders who sold shares, Nichols Christian Todd disposed of 27,134 shares on May 30 at a per-share price of $28.93. This resulted in the SVP, Chief Commercial Officer holding 40,984 shares of ALKS after the transaction. In another insider transaction, Wysenski Nancy sold 41,250 shares at $31.24 per share on May 09. Company shares held by the Director now total 15,829.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for ALKS in the last 3 months, the mean price target is $36.67 with high estimates of $49.00 and low estimates of $30.00. In terms of 52-week highs and lows, ALKS has a high of $33.71 and a low of $21.75.
As of this writing, ALKS has an earnings estimate of $Alkermes plc per share for the current quarter. EPS was calculated based on a consensus of Alaska Air Group, Inc. estimates, with a high estimate of $Aligos Therapeutics, Inc. per share and a lower estimate of $Alkami Technology, Inc.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ALKS’s latest balance sheet shows that the firm has $765.74M in Cash & Short Term Investments as of fiscal 2021. There were $295.80M in debt and $471.29M in liabilities at the time. Its Book Value Per Share was $7.70, while its Total Shareholder’s Equity was $1.11B.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALKS is Buy with a score of 3.86.